human menopausal gonadotropin
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02544191 | Dec 2015 → Dec 2017 | azoospermia | Jinling Hospital, China | Unknown | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT03687606 | Oct 2018 → Oct 2024 | Kallmann syndrome, infertility disorder | Tongji Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03209687 | Jul 2017 → Jul 2024 | infertility disorder | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT02880280 | Aug 2016 → Aug 2017 | Kallmann syndrome | Beijing Children's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00976651 | Jan → Nov 2009 | infertility disorder | University Hospital Brussels | Completed | No outcome recorded |
| Phase 4 | NCT00830492 | Jan → Dec 2008 | ovarian hyperstimulation syndrome | Yazd Research & Clinical Center for Infertility | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05103228 | Dec 2021 → Jul 2023 | infertility disorder, ovarian dysfunction | Peter Kovacs MD | Completed | No outcome recorded |
| — | NCT03291821 | Dec 2017 → Dec 2019 | female infertility | IVI Madrid | Completed | No outcome recorded |
| Comparator or background therapy13 trials | ||||||
| Phase 3 | NCT00669786 Comparator | — | — | Instituto Valenciano de Infertilidad, IVI VALENCIA | Completed | No outcome recorded |
| Phase 4 | NCT04724486 Background | Aug 2020 → Mar 2022 | infertility disorder | Damascus University | Completed | No outcome recorded |
| Phase 4 | NCT04727684 Background | Aug 2020 → Feb 2022 | infertility disorder, polycystic ovary syndrome | Damascus University | Completed | No outcome recorded |
| Phase 4 | NCT04724343 Background | Dec 2019 → Jan 2022 | infertility disorder | Damascus University | Completed | No outcome recorded |
| Phase 4 | NCT04727671 Background | Dec 2019 → Aug 2021 | infertility disorder, polycystic ovary syndrome | Damascus University | Completed | No outcome recorded |
| Phase 4 | NCT03784404 Comparator | Dec 2018 → Dec 2019 | ovarian endometriosis | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT02896023 Comparator | Sep 2016 → Jan 2020 | ovarian dysfunction | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT02458963 Comparator | Jan 2016 → Apr 2017 | infertility disorder, polycystic ovary syndrome | Mohamed Sayed Abdelhafez | Withdrawn | No outcome recorded |
| — | NCT05112692 Comparator | Nov 2021 → Nov 2023 | polycystic ovary syndrome | Mansoura University | Unknown | No outcome recorded |
| — | NCT03402620 Comparator | Jan → Jun 2018 | — | Cairo University | Completed | No outcome recorded |
| — | NCT02940535 Background | Dec 2016 → Dec 2019 | anovulation, female infertility | Navy General Hospital, Beijing | Unknown | No outcome recorded |
| — | NCT02158689 Comparator | Jun 2014 → Aug 2015 | — | Ercan Bastu | Completed | No outcome recorded |
| — | NCT03484611 Comparator | Jan 2013 → Apr 2018 | — | Cairo University | Unknown | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 23 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human menopausal gonadotropin | “Then human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) were injected to stimulate them to ameliorate the ability of testicular spermatogenesis.” PMID 30243299 ↗ Sep 201820“Controlled ovarian stimulation was then started on day 3 using Human Menopausal Gonadotropin (Menogon; Ferring).” NCT03784404 ↗ “75 IU human menopausal gonadotropin (Menogon, ferring, pharmacenticals , Germany)” NCT00830492 ↗ “Human menopausal gonadotropin 75 IU ampoules start at cycle day 2” NCT03402620 ↗ “Human Menopausal Gonadotropin (HMG)” NCT02458963 ↗ “Human menopausal gonadotropin” NCT03484611 ↗ |
| Known as | HMG | “ovarian stimulation will commence with recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG) and the dose will be adjusted according...” NCT04727684 ↗9“Then human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) were injected to stimulate them to ameliorate the ability of testicular spermatogenesis.” PMID 30243299 ↗ Sep 2018 “Human Menopausal Gonadotrophin (HMG) 150-225 international unit/day (IU/d) via intramuscular injection” NCT05112692 ↗ “recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG)” NCT04724343 ↗ “recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG)” NCT04727671 ↗ “recombinant Follicle-Stimulating Hormone (r-FSH) or r-FSH + human Menopausal Gonadotropin (hMG)” NCT04724486 ↗ “Human Menopausal Gonadotropin (HMG) & - Recombinant Follicle Stimulating Hormone (r-FSH)” NCT00669786 ↗ “Human menopausal gonadotropin/human chorionic gonadotropin (HMG/HCG)” NCT02940535 ↗ “Human Menopausal Gonadotropin (HMG)” NCT02458963 ↗ “human menopausal gonadotropin (hMG)” NCT02158689 ↗ |
| Known as | hpHMG | “Highly purified hMG (hp-hMG) has recently shown better cycle outcome than the recombinant FSH (rFSH)” PMID 18583332 ↗ Jun 20081“150 IU follitropin alpha + 75 IU highly purified human menopausal gonadotropin (hpHMG)” NCT05103228 ↗ |
| Known as | Human Menopausal Gonadotropin (HMG) | “Human Menopausal Gonadotropin (HMG)” NCT02458963 ↗1“Human Menopausal Gonadotropin(hMG)” NCT02880280 ↗ |
| Known as | Menogon | “Controlled ovarian stimulation was then started on day 3 using Human Menopausal Gonadotropin (Menogon; Ferring).” NCT03784404 ↗1“75 IU human menopausal gonadotropin (Menogon, ferring, pharmacenticals , Germany)” NCT00830492 ↗ |
| Known as | merional | “HMG(merional, IBSA)” NCT03484611 ↗ |
| Known as | Urofollitropin for Injection | “After 3 months from the first Goserelin injection, all subjects were treated with hMG (Urofollitropin for Injection, Livzon Pharm Group Inc., China) at a dose of 150 IU every 3...” NCT02544191 ↗ |
| Route | Subcutaneous | “This group will take daily subcutaneous 75 IU (international unit) of human menopausal gonadotropin (HMG)” NCT03209687 ↗ |